Antiarrhythmic Drug Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

By: HDIN Research Published: 2025-05-25 Pages: 90
Market Research Report Price
  • Single User License (1 Users) $ 3,200
  • Team License (2~5 Users) $ 4,200
  • Corporate License (>5 Users) $ 5,200
Antiarrhythmic Drugs Market Summary
Introduction and Market Overview
Antiarrhythmic drugs, including sodium channel blockers, beta blockers, potassium channel blockers, calcium channel blockers, and others, address cardiovascular conditions like atrial fibrillation (AF), affecting 33 million people globally, and ventricular arrhythmias. The market is driven by an aging population (1 billion over 60 in 2020, projected to reach 2.1 billion by 2050), with AF prevalence reaching 10-17% in those over 65. Lifestyle factors like hypertension (1.2 billion cases) and diabetes (422 million cases) increase arrhythmia risk. Novel drugs like AP30663 and sustained-release propafenone improve compliance by 20%. The global antiarrhythmic drugs market is estimated at USD 600-1,200 million in 2025, with a CAGR of 4%-8% through 2030.

Regional Market Trends
 North America: The U.S. leads with high AF prevalence and novel drug adoption, while Canada focuses on preventive care.
 Europe: Germany, France, and the UK drive growth with advanced cardiology care.
 Asia Pacific: China and Japan see rising cases due to aging, with India emphasizing generics.
 Rest of the World: Brazil expands CVD treatment access, while the Middle East addresses lifestyle-related arrhythmias.

Distribution Channel Analysis
 Hospital Pharmacies: Expected growth of 4.5%-8.5%, driven by acute arrhythmia cases. Trends focus on ICU delivery.
 Retail Pharmacies: Projected growth of 4.0%-8.0%, linked to chronic management. Advances emphasize accessibility.
 Others: Anticipated growth of 3.8%-7.8%, covering online platforms. Trends highlight digital prescriptions.

Type Analysis
 Sodium Channel Blockers: Expected growth of 4.0%-8.0%, for ventricular arrhythmias. Trends focus on propafenone improvements.
 Beta Blockers: Projected growth of 4.2%-8.2%, widely used for AF. Advances emphasize long-acting formulations.
 Potassium Channel Blockers: Anticipated growth of 4.5%-8.5%, effective for AF conversion. Trends highlight sotalol innovations.
 Calcium Channel Blockers: Expected growth of 4.0%-8.0%, for rate control. Developments prioritize safety profiles.
 Others: Projected growth of 3.8%-7.8%, covering novel agents. Trends focus on SK channel inhibitors.

Key Market Players
 Pfizer: Offers beta blockers for arrhythmia management.
 Sanofi: Supplies antiarrhythmic therapies for AF.
 Novartis: Develops calcium channel blockers.
 Merck: Provides potassium channel blockers.
 GSK: Innovates arrhythmia treatments.

Porter’s Five Forces Analysis
 Threat of New Entrants: Moderate, as high R&D costs exist, but generics lower barriers.
 Threat of Substitutes: Moderate, with non-pharmacological treatments like ablation competing, but drugs are essential for acute cases.
 Bargaining Power of Buyers: High, due to generic availability driving price competition.
 Bargaining Power of Suppliers: Low, with multiple suppliers of active ingredients.
 Competitive Rivalry: High, with companies competing on efficacy, safety, and cost.

Market Opportunities and Challenges
Opportunities:
 Addressing 33 million AF patients globally.
 Targeting an aging population, with 10-17% AF prevalence.
 Leveraging novel drugs, improving compliance by 20%.
 Managing lifestyle-driven arrhythmias, with 1.2 billion hypertension cases.
 Expanding generic antiarrhythmic options.
 Supporting ICU arrhythmia management, with 30% prevalence.
Challenges:
 Price erosion due to generic competition.
 Side effects of antiarrhythmic drugs requiring monitoring.
 Competition from ablation procedures.
 Regulatory delays for novel therapies.
 Limited access in low-income regions.
Table of Contents
Chapter 1 Executive Summary
Chapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Antiarrhythmic Drug Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Antiarrhythmic Drug Market in North America (2020-2030)
8.1 Antiarrhythmic Drug Market Size
8.2 Antiarrhythmic Drug Market by End Use
8.3 Competition by Players/Suppliers
8.4 Antiarrhythmic Drug Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Antiarrhythmic Drug Market in South America (2020-2030)
9.1 Antiarrhythmic Drug Market Size
9.2 Antiarrhythmic Drug Market by End Use
9.3 Competition by Players/Suppliers
9.4 Antiarrhythmic Drug Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Antiarrhythmic Drug Market in Asia & Pacific (2020-2030)
10.1 Antiarrhythmic Drug Market Size
10.2 Antiarrhythmic Drug Market by End Use
10.3 Competition by Players/Suppliers
10.4 Antiarrhythmic Drug Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southest Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Antiarrhythmic Drug Market in Europe (2020-2030)
11.1 Antiarrhythmic Drug Market Size
11.2 Antiarrhythmic Drug Market by End Use
11.3 Competition by Players/Suppliers
11.4 Antiarrhythmic Drug Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Antiarrhythmic Drug Market in MEA (2020-2030)
12.1 Antiarrhythmic Drug Market Size
12.2 Antiarrhythmic Drug Market by End Use
12.3 Competition by Players/Suppliers
12.4 Antiarrhythmic Drug Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Antiarrhythmic Drug Market (2020-2025)
13.1 Antiarrhythmic Drug Market Size
13.2 Antiarrhythmic Drug Market by End Use
13.3 Competition by Players/Suppliers
13.4 Antiarrhythmic Drug Market Size by Type
Chapter 14 Global Antiarrhythmic Drug Market Forecast (2025-2030)
14.1 Antiarrhythmic Drug Market Size Forecast
14.2 Antiarrhythmic Drug Application Forecast
14.3 Competition by Players/Suppliers
14.4 Antiarrhythmic Drug Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Pfizer
15.1.1 Company Profile
15.1.2 Main Business and Antiarrhythmic Drug Information
15.1.3 SWOT Analysis of Pfizer
15.1.4 Pfizer Antiarrhythmic Drug Sales, Revenue, Price and Gross Margin (2020-2025)
15.2 Sanofi
15.2.1 Company Profile
15.2.2 Main Business and Antiarrhythmic Drug Information
15.2.3 SWOT Analysis of Sanofi
15.2.4 Sanofi Antiarrhythmic Drug Sales, Revenue, Price and Gross Margin (2020-2025)
15.3 Novartis
15.3.1 Company Profile
15.3.2 Main Business and Antiarrhythmic Drug Information
15.3.3 SWOT Analysis of Novartis
15.3.4 Novartis Antiarrhythmic Drug Sales, Revenue, Price and Gross Margin (2020-2025)
15.4 Merck
15.4.1 Company Profile
15.4.2 Main Business and Antiarrhythmic Drug Information
15.4.3 SWOT Analysis of Merck
15.4.4 Merck Antiarrhythmic Drug Sales, Revenue, Price and Gross Margin (2020-2025)
15.5 GSK
15.5.1 Company Profile
15.5.2 Main Business and Antiarrhythmic Drug Information
15.5.3 SWOT Analysis of GSK
15.5.4 GSK Antiarrhythmic Drug Sales, Revenue, Price and Gross Margin (2020-2025)
15.6 Viatris
15.6.1 Company Profile
15.6.2 Main Business and Antiarrhythmic Drug Information
15.6.3 SWOT Analysis of Viatris
15.6.4 Viatris Antiarrhythmic Drug Sales, Revenue, Price and Gross Margin (2020-2025)
15.7 Baxter International
15.7.1 Company Profile
15.7.2 Main Business and Antiarrhythmic Drug Information
15.7.3 SWOT Analysis of Baxter International
15.7.4 Baxter International Antiarrhythmic Drug Sales, Revenue, Price and Gross Margin (2020-2025)
15.8 Mayne Pharma
15.8.1 Company Profile
15.8.2 Main Business and Antiarrhythmic Drug Information
15.8.3 SWOT Analysis of Mayne Pharma
15.8.4 Mayne Pharma Antiarrhythmic Drug Sales, Revenue, Price and Gross Margin (2020-2025)
Please ask for sample pages for full companies list
Table Abbreviation And Acronyms
Table Research Scope Of Antiarrhythmic Drug Report
Table Data Sources Of Antiarrhythmic Drug Report
Table Major Assumptions Of Antiarrhythmic Drug Report
Table Antiarrhythmic Drug Classification
Table Antiarrhythmic Drug Applications
Table Drivers Of Antiarrhythmic Drug Market
Table Restraints Of Antiarrhythmic Drug Market
Table Opportunities Of Antiarrhythmic Drug Market
Table Threats Of Antiarrhythmic Drug Market
Table Raw Materials Suppliers
Table Different Production Methods Of Antiarrhythmic Drug
Table Cost Structure Analysis Of Antiarrhythmic Drug
Table Key End Users
Table Latest News Of Antiarrhythmic Drug Market
Table Merger And Acquisition
Table Planned/Future Project Of Antiarrhythmic Drug Market
Table Policy Of Antiarrhythmic Drug Market
Table 2020-2030 North America Antiarrhythmic Drug Market Size
Table 2020-2030 North America Antiarrhythmic Drug Market Size By Application
Table 2020-2025 North America Antiarrhythmic Drug Key Players Revenue
Table 2020-2025 North America Antiarrhythmic Drug Key Players Market Share
Table 2020-2030 North America Antiarrhythmic Drug Market Size By Type
Table 2020-2030 United States Antiarrhythmic Drug Market Size
Table 2020-2030 Canada Antiarrhythmic Drug Market Size
Table 2020-2030 Mexico Antiarrhythmic Drug Market Size
Table 2020-2030 South America Antiarrhythmic Drug Market Size
Table 2020-2030 South America Antiarrhythmic Drug Market Size By Application
Table 2020-2025 South America Antiarrhythmic Drug Key Players Revenue
Table 2020-2025 South America Antiarrhythmic Drug Key Players Market Share
Table 2020-2030 South America Antiarrhythmic Drug Market Size By Type
Table 2020-2030 Brazil Antiarrhythmic Drug Market Size
Table 2020-2030 Argentina Antiarrhythmic Drug Market Size
Table 2020-2030 Chile Antiarrhythmic Drug Market Size
Table 2020-2030 Peru Antiarrhythmic Drug Market Size
Table 2020-2030 Asia & Pacific Antiarrhythmic Drug Market Size
Table 2020-2030 Asia & Pacific Antiarrhythmic Drug Market Size By Application
Table 2020-2025 Asia & Pacific Antiarrhythmic Drug Key Players Revenue
Table 2020-2025 Asia & Pacific Antiarrhythmic Drug Key Players Market Share
Table 2020-2030 Asia & Pacific Antiarrhythmic Drug Market Size By Type
Table 2020-2030 China Antiarrhythmic Drug Market Size
Table 2020-2030 India Antiarrhythmic Drug Market Size
Table 2020-2030 Japan Antiarrhythmic Drug Market Size
Table 2020-2030 South Korea Antiarrhythmic Drug Market Size
Table 2020-2030 Southeast Asia Antiarrhythmic Drug Market Size
Table 2020-2030 Australia Antiarrhythmic Drug Market Size
Table 2020-2030 Europe Antiarrhythmic Drug Market Size
Table 2020-2030 Europe Antiarrhythmic Drug Market Size By Application
Table 2020-2025 Europe Antiarrhythmic Drug Key Players Revenue
Table 2020-2025 Europe Antiarrhythmic Drug Key Players Market Share
Table 2020-2030 Europe Antiarrhythmic Drug Market Size By Type
Table 2020-2030 Germany Antiarrhythmic Drug Market Size
Table 2020-2030 France Antiarrhythmic Drug Market Size
Table 2020-2030 United Kingdom Antiarrhythmic Drug Market Size
Table 2020-2030 Italy Antiarrhythmic Drug Market Size
Table 2020-2030 Spain Antiarrhythmic Drug Market Size
Table 2020-2030 Belgium Antiarrhythmic Drug Market Size
Table 2020-2030 Netherlands Antiarrhythmic Drug Market Size
Table 2020-2030 Austria Antiarrhythmic Drug Market Size
Table 2020-2030 Poland Antiarrhythmic Drug Market Size
Table 2020-2030 Russia Antiarrhythmic Drug Market Size
Table 2020-2030 Mea Antiarrhythmic Drug Market Size
Table 2020-2030 Mea Antiarrhythmic Drug Market Size By Application
Table 2020-2025 Mea Antiarrhythmic Drug Key Players Revenue
Table 2020-2025 Mea Antiarrhythmic Drug Key Players Market Share
Table 2020-2030 Mea Antiarrhythmic Drug Market Size By Type
Table 2020-2030 Egypt Antiarrhythmic Drug Market Size
Table 2020-2030 Israel Antiarrhythmic Drug Market Size
Table 2020-2030 South Africa Antiarrhythmic Drug Market Size
Table 2020-2030 Gulf Cooperation Council Countries Antiarrhythmic Drug Market Size
Table 2020-2030 Turkey Antiarrhythmic Drug Market Size
Table 2020-2025 Global Antiarrhythmic Drug Market Size By Region
Table 2020-2025 Global Antiarrhythmic Drug Market Size Share By Region
Table 2020-2025 Global Antiarrhythmic Drug Market Size By Application
Table 2020-2025 Global Antiarrhythmic Drug Market Share By Application
Table 2020-2025 Global Antiarrhythmic Drug Key Vendors Revenue
Table 2020-2025 Global Antiarrhythmic Drug Key Vendors Market Share
Table 2020-2025 Global Antiarrhythmic Drug Market Size By Type
Table 2020-2025 Global Antiarrhythmic Drug Market Share By Type
Table 2025-2030 Global Antiarrhythmic Drug Market Size By Region
Table 2025-2030 Global Antiarrhythmic Drug Market Size Share By Region
Table 2025-2030 Global Antiarrhythmic Drug Market Size By Application
Table 2025-2030 Global Antiarrhythmic Drug Market Share By Application
Table 2025-2030 Global Antiarrhythmic Drug Key Vendors Revenue
Table 2025-2030 Global Antiarrhythmic Drug Key Vendors Market Share
Table 2025-2030 Global Antiarrhythmic Drug Market Size By Type
Table 2025-2030 Antiarrhythmic Drug Global Market Share By Type

Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Antiarrhythmic Drug Picture
Figure 2020-2030 North America Antiarrhythmic Drug Market Size And Cagr
Figure 2020-2030 South America Antiarrhythmic Drug Market Size And Cagr
Figure 2020-2030 Asia & Pacific Antiarrhythmic Drug Market Size And Cagr
Figure 2020-2030 Europe Antiarrhythmic Drug Market Size And Cagr
Figure 2020-2030 Mea Antiarrhythmic Drug Market Size And Cagr
Figure 2020-2025 Global Antiarrhythmic Drug Market Size And Growth Rate
Figure 2025-2030 Global Antiarrhythmic Drug Market Size And Growth Rate

Research Methodology

  • Market Estimated Methodology:

    Bottom-up & top-down approach, supply & demand approach are the most important method which is used by HDIN Research to estimate the market size.

1)Top-down & Bottom-up Approach

Top-down approach uses a general market size figure and determines the percentage that the objective market represents.

Bottom-up approach size the objective market by collecting the sub-segment information.

2)Supply & Demand Approach

Supply approach is based on assessments of the size of each competitor supplying the objective market.

Demand approach combine end-user data within a market to estimate the objective market size. It is sometimes referred to as bottom-up approach.

  • Forecasting Methodology
  • Numerous factors impacting the market trend are considered for forecast model:
  • New technology and application in the future;
  • New project planned/under contraction;
  • Global and regional underlying economic growth;
  • Threatens of substitute products;
  • Industry expert opinion;
  • Policy and Society implication.
  • Analysis Tools

1)PEST Analysis

PEST Analysis is a simple and widely used tool that helps our client analyze the Political, Economic, Socio-Cultural, and Technological changes in their business environment.

  • Benefits of a PEST analysis:
  • It helps you to spot business opportunities, and it gives you advanced warning of significant threats.
  • It reveals the direction of change within your business environment. This helps you shape what you’re doing, so that you work with change, rather than against it.
  • It helps you avoid starting projects that are likely to fail, for reasons beyond your control.
  • It can help you break free of unconscious assumptions when you enter a new country, region, or market; because it helps you develop an objective view of this new environment.

2)Porter’s Five Force Model Analysis

The Porter’s Five Force Model is a tool that can be used to analyze the opportunities and overall competitive advantage. The five forces that can assist in determining the competitive intensity and potential attractiveness within a specific area.

  • Threat of New Entrants: Profitable industries that yield high returns will attract new firms.
  • Threat of Substitutes: A substitute product uses a different technology to try to solve the same economic need.
  • Bargaining Power of Customers: the ability of customers to put the firm under pressure, which also affects the customer's sensitivity to price changes.
  • Bargaining Power of Suppliers: Suppliers of raw materials, components, labor, and services (such as expertise) to the firm can be a source of power over the firm when there are few substitutes.
  • Competitive Rivalry: For most industries the intensity of competitive rivalry is the major determinant of the competitiveness of the industry.

3)Value Chain Analysis

Value chain analysis is a tool to identify activities, within and around the firm and relating these activities to an assessment of competitive strength. Value chain can be analyzed by primary activities and supportive activities. Primary activities include: inbound logistics, operations, outbound logistics, marketing & sales, service. Support activities include: technology development, human resource management, management, finance, legal, planning.

4)SWOT Analysis

SWOT analysis is a tool used to evaluate a company's competitive position by identifying its strengths, weaknesses, opportunities and threats. The strengths and weakness is the inner factor; the opportunities and threats are the external factor. By analyzing the inner and external factors, the analysis can provide the detail information of the position of a player and the characteristics of the industry.

  • Strengths describe what the player excels at and separates it from the competition
  • Weaknesses stop the player from performing at its optimum level.
  • Opportunities refer to favorable external factors that the player can use to give it a competitive advantage.
  • Threats refer to factors that have the potential to harm the player.
  • Data Sources
Primary Sources Secondary Sources
Face to face/Phone Interviews with market participants, such as:
Manufactures;
Distributors;
End-users;
Experts.
Online Survey
Government/International Organization Data:
Annual Report/Presentation/Fact Book
Internet Source Information
Industry Association Data
Free/Purchased Database
Market Research Report
Book/Journal/News

Why HDIN Research.com?

More options to meet your budget: you can choose Multi-user report, customized report even only specific data you need

 

Plenty of third-party databases and owned databases support

 

Accurate market information supported by Top Fortune 500 Organizations

 

24/7 purchase support and after-service support

 

Protect customer privacy

ABOUT HDIN RESEARCH

HDIN Research focuses on providing market consulting services. As an independent third-party consulting firm, it is committed to providing in-depth market research and analysis reports.

OUR LOCATION

Room 208-069, Floor 2, Building 6, No. 1, Shangdi 10th Street, Haidian District, Beijing, PR China
+86-010-82142830
sales@hdinresearch.com

QUICK LINKS